Inovio Pharmaceuticals Inc (NASDAQ:INO)
| 20.23 Delayed Data As of Aug 07 |  -0.10 / -0.49%Today’s Change | 1.92 Today|||52-Week Range 33.79 | +513.03% Year-to-Date |
Latest INO News | Press Releases
| Here's How to Build the Safest But Most Promising Coronavirus Portfolio Jul 31 / MotleyFool.com - Paid Partner Content | Biotech Bonanza - Second Half Outlook Jul 28 / Seeking Alpha - Paid Partner Content |
| Why Inovio Stock Is Jumping Today Jul 30 / MotleyFool.com - Paid Partner Content | Better Coronavirus Stock: Inovio vs. Vaxart Jul 28 / MotleyFool.com - Paid Partner Content |
| Inovio rallies on encouraging preclinical results on COVID-19 vaccine Jul 30 / Seeking Alpha - Paid Partner Content | 3 Terrible Stocks Robinhood Investors Are Selling (Finally!) Jul 28 / MotleyFool.com - Paid Partner Content |
| Got $10,000? Invest in These 3 Coronavirus Vaccine Stocks Jul 29 / MotleyFool.com - Paid Partner Content | Here's Your Guide to the Coronavirus Vaccine Leaders Jul 26 / MotleyFool.com - Paid Partner Content |
| Inovio up 4% on Orphan Drug tag for INO-3107 Jul 29 / Seeking Alpha - Paid Partner Content | Why Is Everyone Talking About Novavax Stock? Jul 26 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 20.33 |
| Today’s open | 21.80 |
| Day’s range | 19.90 - 21.05 |
| Volume | 157,882 |
| Average volume (3 months) | 35,502,924 |
| Market cap | $3.1B |
Data as of 4:58pm ET, 08/07/2020
Growth & Valuation
| Earnings growth (last year) | -15.39% |
| Earnings growth (this year) | +43.29% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -86.51% |
| P/E ratio | NM |
| Price/Sales | 79.23 |
| Price/Book | 573.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARNAArena Pharmaceutical... | -1.37 | -2.12% |
| OPKOPKO Health Inc | -0.03 | -0.53% |
| CCXIChemoCentryx Inc | +0.68 | +1.25% |
| PTCTPTC Therapeutics Inc | +0.80 | +1.70% |
Data as of 3:59pm ET, 08/07/2020
Financials
| Next reporting date | August 11, 2020 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $4.1M |
| Annual profit (last year) | -$119.4M |
| Net profit margin | -2,902.75% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Plymouth Meeting, Pennsylvania |
Forecasts
